Home / Oncology News
Oncology & Private Practice News
Recent headlines from leading oncology journals and practice publications, gathered automatically every week.
Updated weekly. Last refreshed . Headlines link to the original publishers.
Research & Journals
- Global Proposal for the TNM Staging System for Poorly Differentiated Thyroid CancerJAMA Oncology ·
- Trends in Racial and Ethnic Representation in the Oncology Trainee WorkforceJAMA Oncology ·
- HB0025, a Novel Anti–PD-L1/VEGF Trap Bispecific Antibody Plus Chemotherapy in Advanced NSCLCJAMA Oncology ·
- Prognostic vs Predictive Value of ctDNA for Chemotherapy Planning and Discrepancy in Visual Presentation of Overall SurvivalJAMA Oncology ·
- Postsurgical ctDNA in Chemotherapy Planning and Discrepancy in Visual Presentation of OSJAMA Oncology ·
- Prognostic vs Predictive Value of ctDNA for Chemotherapy Planning and Discrepancy in Visual Presentation of Overall SurvivalJAMA Oncology ·
- PARP and Androgen-Signaling Inhibition in Metastatic Prostate CancerNEJM ·
- Anbenitamab plus HB1801 for HER2-Positive Advanced Breast CancerNEJM ·
- Durvalumab, Tremelimumab, and Enfortumab Vedotin in Muscle-Invasive Bladder CancerNEJM ·
- Tarlatamab–Durvalumab Maintenance for Extensive-Stage Small-Cell Lung CancerNEJM ·
Practice, Policy & Industry
- Patient-Provider Communication, Treatment, and Survival in a Population-Based Cohort: The North Carolina-Louisiana Prostate Cancer ProjectJCO Oncology Practice ·
- Time-of-Day of Initial Immune Checkpoint Inhibitor Administration and Its Impact on Outcomes in Metastatic Non–Small Cell Lung CancerJCO Oncology Practice ·
- Impact of Zinc Supplementation and Topical Clobetasol on the Prevention of Regorafenib-Induced Hand-Foot Skin Reaction: The ZINCLO-HAND StudyJCO Oncology Practice ·
- Optimizing Cancer Care Delivery: Capacity and Cost Benefits of Home-Based Self-Administration of Subcutaneous TrastuzumabJCO Oncology Practice ·
- Local Therapy of Metastases in Colorectal Cancer: Utilization and Survival in a Nationwide PopulationJCO Oncology Practice ·
- Germline Testing in Upper Tract Urothelial Carcinoma: A Nationwide Claims-Based AnalysisJCO Oncology Practice ·
Clinical News
- Afami-Cel Outcomes Are Tied to MAGE-A4 Expression, Tumor Burden in Synovial SarcomaOncLive ·
- STX-001 Produces Durable Systemic Responses in PD-1–Resistant MelanomaOncLive ·
- RP1 Plus Nivolumab Preserves Quality-Adjusted Survival in Advanced Melanoma After Anti–PD-1 TherapyOncLive ·
- VET3-TGI Generates Responses in Checkpoint Inhibitor–Refractory Cutaneous CancersOncLive ·
- Closing the HCC Surveillance Gap in MASLD Without CirrhosisCancerNetwork ·
- Dr Isakoff on Data for Invikafusp Alfa Plus Sacituzumab Govitecan in Advanced HR+ or Triple-Negative Breast CancerOncLive ·
- Dr Graham on Data for JNJ-87189401 Plus Pasritamig in mCRPCOncLive ·
- Weighing HCC Surveillance for Patients With MASLD and F3 FibrosisCancerNetwork ·
- Closing the Gap Between Tumor Board Recommendations and Liver Cancer CareCancerNetwork ·
- Rethinking Surveillance and Multidisciplinary Care in MASLD-Related HCCCancerNetwork ·
- Avoiding Chemo in Breast Cancer; Psychedelic Medication for DepressionMedPage Today ·
- Building Systems to Catch Liver and Other Cancers in Patients With MASLDCancerNetwork ·
- Eliciting Patient Preferences to Guide HCC Treatment DecisionsCancerNetwork ·
- Gene Therapy Under Scrutiny After Nine Tumor ReportsMedPage Today ·
- Hormone Therapy and Cancer Risk; Oncology Pay Cut; Mammograms Post-Double MastectomyMedPage Today ·
Headlines and links belong to their publishers. Northstar and Catalyst 3 aren't affiliated with them, and listing an article isn't an endorsement.
Page last updated